Obesity and the pathogenesis of barrett's esophagus

Energy Balance and Gastrointestinal Cancer

Volumn , Issue , 2012, Pages 77-92

  Leidner, Rom ^a   Chak, Amitabh ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84961303789     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-2367-6_5     Document Type: Chapter

References (57)

1. Sharma P et al (2004) A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 127(1):310-330
2. Jankowski J et al (2010) Diagnosis and management of Barrett's oesophagus. BMJ 341:c4551
3. Taylor JB, Rubenstein JH (2010) Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus. Am J Gastroenterol 105(8):1729, 1730-7; quiz 1738
4. Reid BJ et al (2010) Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 10(2):87-101
5. Dent J et al (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54(5):710-717
6. Fitzgerald RC (2005) Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut 54(Suppl 1):i21-i26
7. Lieberman DA, Oehlke M, Helfand M (1997) Risk factors for Barrett's esophagus in community-based practice GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 92(8):1293-1297
8. Edelstein ZR et al (2009) Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am J Gastroenterol 104(4):834-842
9. Ronkainen J et al (2005) Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129(6):1825-1831
10. Falk GW (2002) Barrett's esophagus. Gastroenterology 122(6):1569-1591
11. Lagergren J et al (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340(11):825-831
12. Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130(11):883-890
13. Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97(2):142-146
14. Thompson CL et al (2008) Carbohydrate consumption and esophageal cancer:an ecological assessment. Am J Gastroenterol 103(3):555-561
15. El-Serag H (2008) The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci 53(9):2307-2312
16. Corley DA et al (2009) Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut 58(2):182-188
17. Thompson OM et al (2009) Vegetable and fruit intakes and risk of Barrett's esophagus in men and women. Am J Clin Nutr 89(3):890-896
18. Ogden CL et al (2010) Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 303(3):242-249
19. Friedenberg FK et al (2008) The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 103(8):2111-2122
20. Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143(3):199-211
21. Jacobson BC et al (2006) Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354(22):2340-2348
22. Kubo A, Corley DA (2006) Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15(5):872-878
23. Chak A et al (2009) Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol 104(8):1913-1921
24. Whiteman DC et al (2008) Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 57(2):173-180
25. Chak A et al (2002) Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 51(3):323-328
26. Gerson LB, Shetler K, Triadafilopoulos G (2002) Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123(2):461-467
27. Stein DJ et al (2005) The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther 22(10):1005-1010
28. Smith KJ et al (2005) Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2481-2486
29. Cook MB et al (2008) A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 103(2):292-300
30. Seidel D et al (2009) The association between body mass index and Barrett's esophagus: a systematic review. Dis Esophagus 22(7):564-570
31. Kamat P et al (2009) Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. Ann Thorac Surg 87(2):655-662
32. Vaughan TL et al (2002) Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 11(8):745-752
33. El-Serag HB et al (2005) Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 100(10):2151-2156
34. Corley DA et al (2007) Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133(1):34-41, quiz 311
35. Edelstein ZR et al (2007) Central adiposity and risk of Barrett's esophagus. Gastroenterology 133(2):403-411
36. Corley DA, Kubo A, Zhao W (2007) Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 56(6):756-762
37. Zhang Y et al (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425-432
38. Considine RV et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292-295
39. Garofalo C, Surmacz E (2006) Leptin and cancer. J Cell Physiol 207(1):12-22
40. Beales IL et al (2007) Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study. BMC Cancer 7:97
41. Beales IL, Ogunwobi OO (2007) Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture. Mol Cell Endocrinol 274(1-2):60-68
42. Ogunwobi O, Mutungi G, Beales IL (2006) Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prosta- glandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147(9):4505-4516
43. Ogunwobi OO, Beales IL (2008) Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells. Mol Cell Endocrinol 296(1-2):94-102
44. Francois F et al (2008) The association of gastric leptin with oesophageal inflammation and metaplasia. Gut 57(1):16-24
45. Kendall BJ et al (2008) Leptin and the risk of Barrett's oesophagus. Gut 57(4):448-454
46. Thompson OM et al (2010) Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction. Obesity (Silver Spring) 18(11):2204-2211
47. Weyer C et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86(5):1930-1935
48. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94(9):1221-1225
49. Wang Y et al (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280(18):18341-18347
50. Konturek PC et al (2008) Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 53(3):597-605
51. Rubenstein JH et al (2009) Association of adiponectin multimers with Barrett's oesophagus. Gut 58(12):1583-1589
52. Xu H et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821-1830
53. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21(6):697-738
54. Ryan AM et al (2008) Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. Ann Surg 247(6):909-915
55. Leitzmann MF et al (2009) Physical activity and esophageal and gastric carcinoma in a large prospective study. Am J Prev Med 36(2):112-119
56. Huerta JM et al (2010) Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort. Cancer Causes Control, http://www.springerlink.com/content /5n272700m7008225/ 21(5):657-669
57. Winzer BM et al (2010) Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus. BMC Cancer 10:292